ミネラル・骨疾患治療の世界市場レポート 2025年

ミネラル・骨疾患治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.1％で46億8,000万米ドルに成長します。予測期間の成長は、QOL治療に対する需要の高まり、個別化医療に対する需要の高まり、ヘルスケアに対する政府支出、早期診断の重要性に対する意識の高まりなどに起因しています。予測期間の主な動向には、医学研究の進歩、医薬品開発、デジタルヘルス、生物学的治療、遠隔医療、遠隔モニタリングなどがあります。

高齢者人口の増加が、今後数年間のミネラル・骨疾患治療市場の成長を牽引すると予想されます。高齢者人口とは、65歳以上の個人を指します。高齢になると、筋肉や骨の量が減少し、筋力低下や筋力低下につながることが多いです。ミネラルや骨の治療は、筋肉、骨、関節の加齢による変化を予防し、骨を強化し、骨量減少の進行を遅らせるのに役立ちます。例えば、2024年7月、英国の政府機関である英国議会の下院図書館は、2022年に英国では全人口の19％にあたる1,270万人が65歳以上になると報告しました。この数は2072年には2,210万人に増加し、人口の27％を占めると予測されています。その結果、高齢者人口の増加がミネラル・骨疾患治療市場の成長に拍車をかけています。

慢性腎臓病の罹患率の上昇がミネラル・骨疾患治療市場の成長を牽引すると予測されます。慢性腎臓病（CKD）は、長期間にわたる腎機能の漸減が特徴です。CKDにおけるミネラル・骨疾患の効果的な治療は、適切なミネラルバランスを維持し、骨の健康を保ち、これらの不均衡に関連する合併症を軽減することを目的としています。2022年3月現在、米国の医療情報源である国立医学図書館のデータによると、世界人口の10％を占める8億人以上の人々が、進行性の病気である慢性腎臓病を患っています。その結果、慢性腎臓病の有病率の増加がミネラル・骨疾患治療市場の成長を促進する主要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のミネラル・骨疾患治療市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のミネラル・骨疾患治療市場：成長率分析
• 世界のミネラル・骨疾患治療市場の実績：規模と成長、2019～2024年
• 世界のミネラル・骨疾患治療市場の予測：規模と成長、2024～2029年、2034年
• 世界のミネラル・骨疾患治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のミネラル・骨疾患治療市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 食事
• 栄養
• 医薬品
• サプリメント
• 透析
• 世界のミネラル・骨疾患治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界のミネラル・骨疾患治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• ホームケア
• 専門クリニック
• その他
• 世界のミネラル・骨疾患治療市場：食事のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• カルシウムを多く含む食品
• ビタミンDを多く含む食品
• リンを多く含む食品
• 世界のミネラル・骨疾患治療市場：栄養のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 栄養カウンセリング
• 栄養強化食品
• 食事代替プログラム
• 世界のミネラル・骨疾患治療市場：医薬品のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ビスフォスフォネート
• ホルモン療法
• RANKリガンド阻害剤
• 世界のミネラル・骨疾患治療市場：サプリメントのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• カルシウムサプリメント
• ビタミンDサプリメント
• マルチビタミンサプリメント
• 世界のミネラル・骨疾患治療市場：透析のサブセグメンテーション：タイプ、実績と予測、2019～2024年、2024～2029年、2034年
• 血液透析
• 腹膜透析
• 持続的腎代替療法（CRRT）

第7章 地域別・国別分析

• 世界のミネラル・骨疾患治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のミネラル・骨疾患治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ミネラル・骨疾患治療市場：競合情勢
• ミネラル・骨疾患治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Takeda Pharmaceutical Co. Ltd.
• Eli Lilly And Company
• Amgen Inc.
• GlaxoSmithKline plc
• Teva Pharmaceuticals Industries Ltd.
• Mylan N.V.
• Daiichi Sankyo Company Limited
• Servier Laboratories Pty Ltd.
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma Limited
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals plc
• Glenmark Pharmaceuticals Ltd.
• Alkem Laboratories Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ミネラル・骨疾患治療市場2029：新たな機会を提供する国
• ミネラル・骨疾患治療市場2029：新たな機会を提供するセグメント
• ミネラル・骨疾患治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Mineral and bone disorder treatment is a therapeutic approach recommended when there is an imbalance in the levels of calcium and phosphorus in the bloodstream. This treatment is aimed at regulating specific minerals and hormones in the blood to prevent damage to the bones and blood vessels.

The key treatments for mineral and bone disorders encompass dietary adjustments, nutritional interventions, medications, the use of supplements, and, in severe cases, dialysis. Dietary modifications involve consuming foods and beverages that promote bone health, reducing the risk of conditions like osteoporosis and mitigating further bone loss. These treatments can be made available through various distribution channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are tailored to different end users, such as hospitals, homecare settings, specialty clinics, and more.

The mineral and bone disorder treatment market research report is one of a series of new reports from The Business Research Company that provides mineral and bone disorder treatment market statistics, including mineral and bone disorder treatment industry global market size, regional shares, competitors with a mineral and bone disorder treatment market share, detailed mineral and bone disorder treatment market segments, market trends and opportunities and any further data you may need to thrive in the mineral and bone disorder treatment industry. This mineral and bone disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mineral and bone disorder treatment market size has grown strongly in recent years. It will grow from $3.3 billion in 2024 to $3.55 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to chronic kidney disease, aging population, rising awareness of mineral and bone disorders, increased availability of mineral and bone disorder treatments, rising disposable income levels.

The mineral and bone disorder treatment market size is expected to see strong growth in the next few years. It will grow to $4.68 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising demand for quality of life treatments, growing demand for personalized medicine, government spending on healthcare, rising awareness of the importance of early diagnosis. Major trends in the forecast period include advancements in medical research, pharmaceutical developments, digital health, biologic therapies, telehealth and remote monitoring.

The growing elderly population is expected to drive the growth of the mineral and bone disorder treatment market in the coming years. The elderly population refers to individuals aged 65 and older. As people age, they often experience a loss of muscle and bone mass, which leads to weakness and reduced strength. Mineral and bone treatments can help prevent age-related changes in muscles, bones, and joints, strengthen bones, and slow the progression of bone loss. For example, in July 2024, the UK Parliament's House of Commons Library, a UK-based government agency, reported that in 2022, 12.7 million people in the UK, or 19% of the total population, were aged 65 or older. This number is projected to increase to 22.1 million by 2072, accounting for 27% of the population. As a result, the rising elderly population is fueling the growth of the mineral and bone disorder treatment market.

The rising incidence of chronic kidney diseases is anticipated to drive the growth of the mineral and bone disorder treatment market. Chronic kidney disease (CKD) is characterized by the gradual loss of kidney function over an extended period. Effective treatment of mineral and bone disorders in CKD aims to maintain appropriate mineral balance, preserve bone health, and mitigate the complications associated with these imbalances. As of March 2022, data from the National Library of Medicine, a US-based medical resource, indicates that over 800 million people globally, constituting 10% of the world's population, suffer from chronic kidney disease, a progressive ailment. Consequently, the increasing prevalence of chronic kidney diseases is a key factor propelling the growth of the mineral and bone disorder treatment market.

Prominent companies in the mineral and bone disorder treatment market are strategically focusing on the development and approval of new products to enhance their market position. The increasing prevalence of chronic kidney diseases, particularly among the aging population, has led to the approval of new drugs for mineral and bone disorders. An example of such an approved drug is TYMLOS (abaloparatide), which contains the active drug abaloparatide, a synthetic form of the human parathyroid hormone. For instance, in December 2022, Radius Health Inc., a biopharmaceutical company based in the United States, successfully obtained approval for TYMLOS (abaloparatide). This drug, an analog of parathyroid hormone-related peptide [PTHrP(1-34)], is designed for the treatment of increasing bone density in men with osteoporosis who are at a high risk of fractures. TYMLOS acts as an anabolic agent for bones by selectively activating the parathyroid hormone 1 receptor (PTH1R) expressed in osteoblasts and osteocytes, resulting in enhanced bone formation and density.

In May 2023, Abiogen Pharma Spa, an Italian pharmaceutical company, acquired EffRx Pharmaceuticals SA for $8.77 million. This strategic acquisition of a majority stake in EffRx aligns with Abiogen's growth strategy, serving as a springboard for international expansion and reinforcing its commitment to addressing osteoarticular and bone metabolism diseases. EffRx Pharmaceuticals SA, headquartered in Switzerland, is actively engaged in the treatment of various disorders, including mineral and bone disorders.

Major companies operating in the mineral and bone disorder treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Co. Ltd., Eli Lilly And Company, Amgen Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Servier Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Cadila Healthcare Ltd., Alembic Pharmaceuticals Limited, Ajanta Pharma Ltd., Abiogen Pharma Spa, Melinta Therapeutics Inc., Intas Pharmaceuticals Ltd., Radius Health Inc., EffRx Pharmaceuticals SA.

North America was the largest region in the mineral and bone disorder treatment market in 2024. The regions covered in mineral and bone disorder treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mineral and bone disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mineral and bone disorder treatment market consists of revenues earned by entities by providing services such as treatment planning, patient education and support and multidisciplinary care. The market value includes the value of related goods sold by the service provider or included within the service offering. The mineral and bone disorder treatment market also includes sales of biphosphates, estrogens, phosphate binders, non-calcium, non-metal-based binders, magnesium-based binders, parathyroid hormone therapy, RANKL (receptor activator of nuclear factor kappa-B ligand) inhibitors and orthopedic implants which are used in providing mineral and bone disorder treatment-related services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mineral And Bone Disorder Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mineral and bone disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mineral and bone disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mineral and bone disorder treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Diet; Nutrition; Medication; Supplements; Dialysis
• 2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Diet: Calcium-Rich Foods; Vitamin D-Enriched Foods; Phosphorus-Rich Foods
• 2) By Nutrition: Nutritional Counseling; Fortified Food Products; Meal Replacement Programs
• 3) By Medication: Bisphosphonates; Hormonal Therapies; RANK Ligand Inhibitors
• 4) By Supplements: Calcium Supplements; Vitamin D Supplements; Multivitamin Supplements
• 5) By Dialysis: Hemodialysis; Peritoneal Dialysis; Continuous Renal Replacement Therapy (CRRT)
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mineral And Bone Disorder Treatment Market Characteristics

3. Mineral And Bone Disorder Treatment Market Trends And Strategies

4. Mineral And Bone Disorder Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Mineral And Bone Disorder Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Mineral And Bone Disorder Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Mineral And Bone Disorder Treatment Market Growth Rate Analysis
• 5.4. Global Mineral And Bone Disorder Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Mineral And Bone Disorder Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Mineral And Bone Disorder Treatment Total Addressable Market (TAM)

6. Mineral And Bone Disorder Treatment Market Segmentation

• 6.1. Global Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diet
• Nutrition
• Medication
• Supplements
• Dialysis
• 6.2. Global Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.3. Global Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.4. Global Mineral And Bone Disorder Treatment Market, Sub-Segmentation Of Diet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcium-Rich Foods
• Vitamin D-Enriched Foods
• Phosphorus-Rich Foods
• 6.5. Global Mineral And Bone Disorder Treatment Market, Sub-Segmentation Of Nutrition, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nutritional Counseling
• Fortified Food Products
• Meal Replacement Programs
• 6.6. Global Mineral And Bone Disorder Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bisphosphonates
• Hormonal Therapies
• RANK Ligand Inhibitors
• 6.7. Global Mineral And Bone Disorder Treatment Market, Sub-Segmentation Of Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcium Supplements
• Vitamin D Supplements
• Multivitamin Supplements
• 6.8. Global Mineral And Bone Disorder Treatment Market, Sub-Segmentation Of Dialysis, Of Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemodialysis
• Peritoneal Dialysis
• Continuous Renal Replacement Therapy (CRRT)

7. Mineral And Bone Disorder Treatment Market Regional And Country Analysis

• 7.1. Global Mineral And Bone Disorder Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Mineral And Bone Disorder Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mineral And Bone Disorder Treatment Market

• 8.1. Asia-Pacific Mineral And Bone Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mineral And Bone Disorder Treatment Market

• 9.1. China Mineral And Bone Disorder Treatment Market Overview
• 9.2. China Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mineral And Bone Disorder Treatment Market

• 10.1. India Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mineral And Bone Disorder Treatment Market

• 11.1. Japan Mineral And Bone Disorder Treatment Market Overview
• 11.2. Japan Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mineral And Bone Disorder Treatment Market

• 12.1. Australia Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mineral And Bone Disorder Treatment Market

• 13.1. Indonesia Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mineral And Bone Disorder Treatment Market

• 14.1. South Korea Mineral And Bone Disorder Treatment Market Overview
• 14.2. South Korea Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mineral And Bone Disorder Treatment Market

• 15.1. Western Europe Mineral And Bone Disorder Treatment Market Overview
• 15.2. Western Europe Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mineral And Bone Disorder Treatment Market

• 16.1. UK Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mineral And Bone Disorder Treatment Market

• 17.1. Germany Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mineral And Bone Disorder Treatment Market

• 18.1. France Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mineral And Bone Disorder Treatment Market

• 19.1. Italy Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mineral And Bone Disorder Treatment Market

• 20.1. Spain Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mineral And Bone Disorder Treatment Market

• 21.1. Eastern Europe Mineral And Bone Disorder Treatment Market Overview
• 21.2. Eastern Europe Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mineral And Bone Disorder Treatment Market

• 22.1. Russia Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mineral And Bone Disorder Treatment Market

• 23.1. North America Mineral And Bone Disorder Treatment Market Overview
• 23.2. North America Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mineral And Bone Disorder Treatment Market

• 24.1. USA Mineral And Bone Disorder Treatment Market Overview
• 24.2. USA Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mineral And Bone Disorder Treatment Market

• 25.1. Canada Mineral And Bone Disorder Treatment Market Overview
• 25.2. Canada Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mineral And Bone Disorder Treatment Market

• 26.1. South America Mineral And Bone Disorder Treatment Market Overview
• 26.2. South America Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mineral And Bone Disorder Treatment Market

• 27.1. Brazil Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mineral And Bone Disorder Treatment Market

• 28.1. Middle East Mineral And Bone Disorder Treatment Market Overview
• 28.2. Middle East Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mineral And Bone Disorder Treatment Market

• 29.1. Africa Mineral And Bone Disorder Treatment Market Overview
• 29.2. Africa Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mineral And Bone Disorder Treatment Market Competitive Landscape And Company Profiles

• 30.1. Mineral And Bone Disorder Treatment Market Competitive Landscape
• 30.2. Mineral And Bone Disorder Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Mineral And Bone Disorder Treatment Market Other Major And Innovative Companies

• 31.1. Takeda Pharmaceutical Co. Ltd.
• 31.2. Eli Lilly And Company
• 31.3. Amgen Inc.
• 31.4. GlaxoSmithKline plc
• 31.5. Teva Pharmaceuticals Industries Ltd.
• 31.6. Mylan N.V.
• 31.7. Daiichi Sankyo Company Limited
• 31.8. Servier Laboratories Pty Ltd.
• 31.9. Sun Pharmaceutical Industries Ltd.
• 31.10. Aurobindo Pharma Limited
• 31.11. Cipla Limited
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Hikma Pharmaceuticals plc
• 31.14. Glenmark Pharmaceuticals Ltd.
• 31.15. Alkem Laboratories Ltd.

32. Global Mineral And Bone Disorder Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mineral And Bone Disorder Treatment Market

34. Recent Developments In The Mineral And Bone Disorder Treatment Market

35. Mineral And Bone Disorder Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Mineral And Bone Disorder Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Mineral And Bone Disorder Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Mineral And Bone Disorder Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer